Marshall Wace’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Sell |
73,415
-142,998
| -66% | -$490K | ﹤0.01% | 2242 |
|
|
2025
Q1 | $641K | Buy |
216,413
+130,833
| +153% | +$387K | ﹤0.01% | 1860 |
|
|
2024
Q4 | $261K | Buy |
+85,580
| New | +$261K | ﹤0.01% | 2123 |
|
|
2024
Q3 | – | Sell |
-200,085
| Closed | -$652K | – | 2636 |
|
|
2024
Q2 | $652K | Sell |
200,085
-38,406
| -16% | -$125K | ﹤0.01% | 1691 |
|
|
2024
Q1 | $1.26M | Sell |
238,491
-110,131
| -32% | -$584K | ﹤0.01% | 1355 |
|
|
2023
Q4 | $1.51M | Buy |
348,622
+134,409
| +63% | +$582K | ﹤0.01% | 1107 |
|
|
2023
Q3 | $563K | Sell |
214,213
-10,580
| -5% | -$27.8K | ﹤0.01% | 1408 |
|
|
2023
Q2 | $794K | Buy |
224,793
+50,977
| +29% | +$180K | ﹤0.01% | 1445 |
|
|
2023
Q1 | $537K | Sell |
173,816
-147,441
| -46% | -$456K | ﹤0.01% | 1621 |
|
|
2022
Q4 | $1.36M | Buy |
+321,257
| New | +$1.36M | ﹤0.01% | 1490 |
|
|
2022
Q1 | – | Sell |
-396,967
| Closed | -$1.21M | – | 3130 |
|
|
2021
Q4 | $1.21M | Buy |
396,967
+373,691
| +1,605% | +$1.14M | ﹤0.01% | 1840 |
|
|
2021
Q3 | $163K | Buy |
+23,276
| New | +$163K | ﹤0.01% | 2235 |
|
|
2019
Q2 | – | Sell |
-6,788
| Closed | -$263K | – | 1684 |
|
|
2019
Q1 | $263K | Sell |
6,788
-5,008
| -42% | -$194K | ﹤0.01% | 1277 |
|
|
2018
Q4 | $241K | Buy |
+11,796
| New | +$241K | ﹤0.01% | 1248 |
|
|
2018
Q3 | – | Sell |
-4,892
| Closed | -$289K | – | 1246 |
|
|
2018
Q2 | $289K | Buy |
+4,892
| New | +$289K | ﹤0.01% | 633 |
|
|
2016
Q2 | – | Sell |
-17,700
| Closed | -$520K | – | 1106 |
|
|
2016
Q1 | $520K | Sell |
17,700
-77,265
| -81% | -$2.27M | 0.01% | 842 |
|
|
2015
Q4 | $7.45M | Buy |
+94,965
| New | +$7.45M | 0.07% | 291 |
|
|
2015
Q2 | – | Sell |
-16,513
| Closed | -$3.9M | – | 1011 |
|
|
2015
Q1 | $3.9M | Buy |
+16,513
| New | +$3.9M | 0.05% | 363 |
|
|
2014
Q3 | – | Sell |
-9,416
| Closed | -$621K | – | 996 |
|
|
2014
Q2 | $621K | Buy |
+9,416
| New | +$621K | 0.01% | 574 |
|